Register for TECENTRIQ Updates
Sign up to receive the latest information about TECENTRIQ
You are now registering for information that is intended for US healthcare professionals.
By registering at this site, you certify that you are a healthcare professional licensed in the United States or its territories and are indicating that you wish to receive information about TECENTRIQ, TECENTRIQ.com, other Genentech Oncology products, and related disease education. Genentech’s intent is to provide information only to healthcare professionals licensed in the United States or its territories who would likely be treating patients within the FDA-approved indications for this product.
Thank you for registering for TECENTRIQ updates
Registration is complete.
We have received your request, and you are now registered to receive updates about TECENTRIQ (atezolizumab), TECENTRIQ.com, other Genentech Oncology products, and related disease information.
Attn: Privacy Office
1 DNA Way
South San Francisco, CA 94080